About UCSF Search UCSF UCSF Medical Center

Kathryn A. Phillips, PhD, MPA

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
phillips_kathryn

Professor of Health Services Research and Health Economics, Department of Clinical Pharmacy, School of Pharmacy; Director/Founder, Center for Translational and Policy Research on Personalized Medicine (TRANSPERS), UCSF

phillipsk@pharmacy.ucsf.edu

Phone: (415) 502-8271 (voice)
Box 0613, UCSF
San Francisco, CA 94143-0613

View on UCSF Profiles


Additional Websites


Education

University of Texas, Austin, BA, 1978, Psychology
Kennedy School of Government, Harvard Univ., Cambridge, MA, MPA, 1986, Policy Analysis
University of California, Berkeley, PhD, 1991, Health Services Research
Center for AIDS Prevention Studies, Univ. of CA San Francisco, Postdoc, 1993, Health Services Research


Professional Experience

  • 1993-1995
    Assistant Research Professor, University of California, San Francisco (UCSF)
  • 1995-1998
    Assistant Professor (non-tenure track), UCSF
  • 1998-2004
    Associate Professor of Health Economics and Health Services Research, UCSF
  • 2007
    Visiting Scholar, Harvard Partners Center for Genetics and Genomics and New England Health Care Institute, Boston, MA
  • 2004-present
    Professor of Health Economics and Health Services Research (tenured) and Director/Founder, Center for Translational and Policy Research on Personalized Medicine (TRANSPERS), Department of Clinical Pharmacy, School of Pharmacy (home department); Institute for Health Policy Studies & UCSF Comprehensive Cancer Center (affiliated faculty) University of California, San Francisco

Honors & Awards

  • 1977
    Phi Beta Kappa
  • 1985-1986
    Long-Term Civilian Training Award for study at Harvard University, Department of Navy
  • 1987
    Special Achievement Award, Federal Aviation Administration
  • 1987-1988
    University of California-Berkeley Graduate Fellowship
  • 1989
    Outstanding Graduate Student Instructor, University of California-Berkeley
  • 2003
    Named as one of the "50 Most Cited HIV Behavioral Researchers in the Past Decade"
  • 2006
    Nominated to HHS Secretary’s Advisory Committee on Genetics, Health, and Society
  • 2009
    Grollman Lecture at the University of Maryland School of Pharmacy
  • 2010
    Director’s Lecture, National Human Genome Research Institute (NHGRI)

Selected Publications

  1. Phillips KA, Trosman JR, Kelley RK, Pletcher MJ, Douglas MP, Weldon CB. Genomic sequencing: assessing the health care system, policy, and big-data implications. Health Aff (Millwood). 2014 Jul 1; 33(7):1246-53.
    View on PubMed
  2. Balakrishnan N, Pritchard J, Ericson M, Grindem C, Phillips K, Jennings S, Mathews K, Tran H, Birkenheuer AJ, Breitschwerdt EB. Prostatitis, Steatitis, and Diarrhea in a Dog following Presumptive Flea-Borne Transmission of Bartonella henselae. J Clin Microbiol. 2014 Sep; 52(9):3447-52.
    View on PubMed
  3. Pletcher MJ, Pignone M, Earnshaw S, McDade C, Phillips KA, Auer R, Zablotska L, Greenland P. Using the coronary artery calcium score to guide statin therapy: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes. 2014 Mar 1; 7(2):276-84.
    View on PubMed
  4. Phillips KA, Ann Sakowski J, Trosman J, Douglas MP, Liang SY, Neumann P. The economic value of personalized medicine tests: what we know and what we need to know. Genet Med. 2014 Mar; 16(3):251-7.
    View on PubMed
  5. Liang SY, Grossman D, Phillips KA. User characteristics and out-of-pocket expenditures for progestin-only versus combined oral contraceptives. Contraception. 2012 Dec; 86(6):666-72.
    View on PubMed
  6. Wang G, Kuppermann M, Kim B, Phillips KA, Ladabaum U. Influence of patient preferences on the cost-effectiveness of screening for lynch syndrome. J Oncol Pract. 2012 May; 8(3 Suppl):e24s-30s.
    View on PubMed
  7. Wang G, Kuppermann M, Kim B, Phillips KA, Ladabaum U. Influence of patient preferences on the cost-effectiveness of screening for Lynch syndrome. Am J Manag Care. 2012 May; 18(5):e179-85.
    View on PubMed
  8. Wang G, Beattie MS, Ponce NA, Phillips KA. Eligibility criteria in private and public coverage policies for BRCA genetic testing and genetic counseling. Genet Med. 2011 Dec; 13(12):1045-50.
    View on PubMed
  9. Elkin EB, Marshall DA, Kulin NA, Ferrusi IL, Hassett MJ, Ladabaum U, Phillips KA. Economic evaluation of targeted cancer interventions: critical review and recommendations. Genet Med. 2011 Oct; 13(10):853-60.
    View on PubMed
  10. Kiely BE, Friedlander ML, Milne RL, Stanhope L, Russell P, Jenkins MA, Weideman P, McLachlan SA, Grant P. Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer. Fam Cancer. 2011 Sep; 10(3):505-14.
    View on PubMed
  11. Harvey SL, Milne RL, McLachlan SA, Friedlander ML, Birch KE, Weideman P. Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families. Breast Cancer Res Treat. 2011 Dec; 130(3):1057-61.
    View on PubMed
  12. Ladabaum U, Wang G, Terdiman J, Blanco A, Kuppermann M, Boland CR, Ford J, Elkin E, Phillips KA. Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis. Ann Intern Med. 2011 Jul 19; 155(2):69-79.
    View on PubMed
  13. Haas JS, Liang SY, Hassett MJ, Shiboski S, Elkin EB, Phillips KA. Gene expression profile testing for breast cancer and the use of chemotherapy, serious adverse effects, and costs of care. Breast Cancer Res Treat. 2011 Nov; 130(2):619-26.
    View on PubMed
  14. Liang SY, Phillips KA, Wang G, Keohane C, Armstrong J, Morris WM, Haas JS. Tradeoffs of using administrative claims and medical records to identify the use of personalized medicine for patients with breast cancer. Med Care. 2011 Jun; 49(6):e1-8.
    View on PubMed
  15. Trosman JR, Van Bebber SL, Phillips KA. Health technology assessment and private payers' coverage of personalized medicine. J Oncol Pract. 2011 May; 7(3 Suppl):18s-24s.
    View on PubMed
  16. Haas JS, Phillips KA, Liang SY, Hassett MJ, Keohane C, Elkin EB, Armstrong J, Toscano M. Genomic testing and therapies for breast cancer in clinical practice. J Oncol Pract. 2011 May; 7(3 Suppl):e1s-7s.
    View on PubMed
  17. Haas JS, Phillips KA, Liang SY, Hassett MJ, Keohane C, Elkin EB, Armstrong J, Toscano M. Genomic testing and therapies for breast cancer in clinical practice. Am J Manag Care. 2011 May; 17(5 Spec No):e174-81.
    View on PubMed
  18. Trosman JR, Van Bebber SL, Phillips KA. Health technology assessment and private payers's coverage of personalized medicine. Am J Manag Care. 2011 May; 17 Suppl 5 Developing:SP53-60.
    View on PubMed
  19. Johnson FR, Mohamed AF, Ozdemir S, Marshall DA, Phillips KA. How does cost matter in health-care discrete-choice experiments? Health Econ. 2011 Mar; 20(3):323-30.
    View on PubMed
  20. Kelley RK, Van Bebber SL, Phillips KA, Venook AP. Personalized medicine and oncology practice guidelines: a case study of contemporary biomarkers in colorectal cancer. J Natl Compr Canc Netw. 2011 Jan; 9(1):13-25.
    View on PubMed

Go to UCSF Profiles, powered by CTSI